Literature DB >> 25238879

Macrophage colony-stimulating factor and cancer: a review.

S Chockalingam1, Siddhartha Sankar Ghosh.   

Abstract

Tumor growth is influenced by a wide variety of external and internal factors. One of the most important mediators of tumor development is our immune system. The nonstop surveillance of the immune system was originally expected to clear the transformed cells from the body and guard against the development of tumor. But contradictory evidences are reported to show the involvement of immune system in supporting the growth and spread of tumor. Tumor infiltrating immune cells, in addition to harboring immunosuppressive activities, also promote angiogenesis and metastasis of tumor. Many growth factors and cytokines are involved in shaping this complex immune microenvironment of the tumor. Macrophage colony-stimulating factor (MCSF) is one such growth factor which is overexpressed in many tumors. In this review, we summarize the basic biology of MCSF, its role in cancer and discuss the involvement of tumor-associated macrophages (TAMs) in tumor development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25238879     DOI: 10.1007/s13277-014-2627-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  89 in total

Review 1.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

2.  IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo.

Authors:  Stephanie K Watkins; Nejat K Egilmez; Jill Suttles; Robert D Stout
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

3.  Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1.

Authors:  J H Harmey; E Dimitriadis; E Kay; H P Redmond; D Bouchier-Hayes
Journal:  Ann Surg Oncol       Date:  1998 Apr-May       Impact factor: 5.344

4.  Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis.

Authors:  G R Ryan; X M Dai; M G Dominguez; W Tong; F Chuan; O Chisholm; R G Russell; J W Pollard; E R Stanley
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

Review 5.  Biology and action of colony--stimulating factor-1.

Authors:  E R Stanley; K L Berg; D B Einstein; P S Lee; F J Pixley; Y Wang; Y G Yeung
Journal:  Mol Reprod Dev       Date:  1997-01       Impact factor: 2.609

6.  Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by a plasma membrane-bound precursor of human CSF-1.

Authors:  J Stein; G V Borzillo; C W Rettenmier
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

7.  Identification of the ligand-binding regions in the macrophage colony-stimulating factor receptor extracellular domain.

Authors:  Z E Wang; G M Myles; C S Brandt; M N Lioubin; L Rohrschneider
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

Review 8.  Tumour-associated macrophages and cancer.

Authors:  Jenny Cook; Thorsten Hagemann
Journal:  Curr Opin Pharmacol       Date:  2013-06-15       Impact factor: 5.547

Review 9.  CSF-1 and its receptor in ovarian, endometrial and breast cancer.

Authors:  B M Kacinski
Journal:  Ann Med       Date:  1995-02       Impact factor: 4.709

10.  CSF-1 deficiency in mice results in abnormal brain development.

Authors:  M D Michaelson; P L Bieri; M F Mehler; H Xu; J C Arezzo; J W Pollard; J A Kessler
Journal:  Development       Date:  1996-09       Impact factor: 6.868

View more
  23 in total

1.  Doxorubicin resistance mediated by cytoplasmic macrophage colony-stimulating factor is associated with switch from apoptosis to autophagic cell death in MCF-7 breast cancer cells.

Authors:  Mengxia Zhang; Hailiang Zhang; Fan Tang; Yuhua Wang; Zhongcheng Mo; Xiaoyong Lei; Shengsong Tang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-24

Review 2.  Inflammation in Hypertension.

Authors:  Liang Xiao; David G Harrison
Journal:  Can J Cardiol       Date:  2020-01-24       Impact factor: 5.223

3.  Combinatorial and Computational Approaches to Identify Interactions of Macrophage Colony-stimulating Factor (M-CSF) and Its Receptor c-FMS.

Authors:  Lior Rosenfeld; Jason Shirian; Yuval Zur; Noam Levaot; Julia M Shifman; Niv Papo
Journal:  J Biol Chem       Date:  2015-09-10       Impact factor: 5.157

4.  Targeting the C-terminus of galectin-9 induces mesothelioma apoptosis and M2 macrophage depletion.

Authors:  Pietro Bertino; Thomas A Premeaux; Tsuyoshi Fujita; Brien K Haun; Michael P Marciel; Fukun W Hoffmann; Alan Garcia; Haining Yiang; Sandra Pastorino; Michele Carbone; Toshiro Niki; John Berestecky; Peter R Hoffmann; Lishomwa C Ndhlovu
Journal:  Oncoimmunology       Date:  2019-04-17       Impact factor: 8.110

Review 5.  Stromal contributions to the carcinogenic process.

Authors:  Mark Spaw; Shrikant Anant; Sufi Mary Thomas
Journal:  Mol Carcinog       Date:  2016-11-05       Impact factor: 4.784

6.  M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors.

Authors:  C Barceló; P Sisó; I de la Rosa; C Megino-Luque; R Navaridas; O Maiques; I Urdanibia; N Eritja; X Soria; M Potrony; N Calbet-Llopart; S Puig; X Matías-Guiu; R M Martí; A Macià
Journal:  Br J Cancer       Date:  2022-06-20       Impact factor: 9.075

7.  Interactions between colon cancer cells and tumor-infiltrated macrophages depending on cancer cell-derived colony stimulating factor 1.

Authors:  Huayang Wang; Qianqian Shao; Jintang Sun; Chao Ma; Wenjuan Gao; Qingjie Wang; Lei Zhao; Xun Qu
Journal:  Oncoimmunology       Date:  2016-01-04       Impact factor: 8.110

Review 8.  Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment.

Authors:  Mansi Saxena; Nina Bhardwaj
Journal:  Trends Cancer       Date:  2018-02

9.  Investigation of the Effects and Mechanisms of Anticancer Action of a Ru(II)-Arene Iminophosphorane Compound in Triple Negative Breast Cancer Cells.

Authors:  Nazia Nayeem; Arefa Yeasmin; Samantha N Cobos; Ali Younes; Karen Hubbard; Maria Contel
Journal:  ChemMedChem       Date:  2021-08-24       Impact factor: 3.466

10.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.